A novel compound mutation of CYP27B1 in a Chinese family with vitamin D-dependent rickets type 1A.

Wei-Wei Hu,Yao-Hua Ke,Jin-Wei He,Wen-Zhen Fu,Chun Wang,Hao Zhang,Hua Yue,Jie-Mei Gu,Zhen-Lin Zhang
DOI: https://doi.org/10.1515/jpem-2013-0183
2014-01-01
Abstract:Objectives: Mutations in the CYP27B1 gene, which encodes vitamin D 1a-hydroxylase, are the genetic basis of vitamin D-dependent rickets type 1A (VDDR1A, MIM 264700). The aim of this study was to investigate a novel CYP27B1 mutation and its clinical manifestations. Methods: VDDR1A was diagnosed based on clinical presentation, a physical examination, bone characteristics on an X-ray, and laboratory results. A molecular model of the CYP27B1 protein was constructed using the SWISS-MODEL server and Swiss-PdbViewer. Results: We sequenced the CYP27B1 gene in a 5-year-old male child who presented with growth retardation and a history of frequent hand, leg, and perioral twitching since the age of 12 months. We identified a compound heterozygous mutation consisting of two missense mutations: one in exon 7 (R389C [c. 1165C > T]) and one in exon 8 (R459C [c. 1375C > T]). We used the wild-type CYP27B1 as a receptor and calcidiol as a ligand to predict the interaction between the R459 site and calcidiol. According to the predicted structure, the wild-type R459 residue localizes to the pocket where CYP27B1 binds to its ligand. Conclusions: According to the Human Gene Mutation Database, the compound heterozygous mutation identified in our patient is novel and has not yet been reported in the literature. This mutation provides a new basis for further research on VDDR1A and for the development of clinical diagnostics.
What problem does this paper attempt to address?